At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 32 enrolled
Drug / intervention
SRP + Injectable Platelet-Rich Fibrin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Application Injectable Platelet-Rich Fibrin (i-PRF) as Adjunct Therapy in the Initial Treatment of Periodontitis
In Brief
A Phase 4 clinical trial evaluating SRP + Injectable Platelet-Rich Fibrin and SRP + placebo for Periodontitis. Completed, enrolled 32 participants across 1 site.
Detailed Summary
Current treatments of periodontitis have limited efficacy since they fail to suppress microorganisms satisfactorily over time. The aim of present study was to investigate whether there are differences between initial treatment of chronic periodontitis (SRP) and SRP in conjunction with injectable platelet-rich fibrin (i-PRF) application.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontitis
CountriesSerbia
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
First PostedNov 2019
Primary CompletionJun 2020
Study CompletionJul 2020
TodayJul 2026
First PostedNov 26, 2019
Enrollment StartOct 2, 2019
Primary CompletionJun 29, 2020
Study CompletionJul 9, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 6.6 years ago
Interventions
SRP + Injectable Platelet-Rich Fibrindrug
Injectable Platelet-Rich Fibrin application as adjunct to scaling and root planing
SRP + placebodrug
Saline application during scaling and root planing